This shortfall also holds true for neurodegenerative diseases, where loss of NRF2 is a well-established driver of neurodegenerative phenotypes, yet restoration of NRF2 signaling remains an unharnessed therapeutic possibility. Here, NFE2L2 is linked to neurodegenerative disease.